SCHEMBL29979147

SCHEMBL29979147

Cc1ccc(NS(=O)(=O)c2ccc(S(=O)(=O)N(C)C)cc2)c(N2CCC(C)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
MCOLN2 Q8IZK6 1/20 0.44
LMNA P02545 4/20 0.44
POLB P06746 3/20 0.44
GAA P10253 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 2/20 0.42
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23057183 1.00 ALDH1A1 (0.48) ALDH1A1MCOLN2LMNAPOLBGAA
SCHEMBL29979144 0.91 ALDH1A1 (0.56) ALDH1A1MCOLN2LMNAPOLBGAA
SCHEMBL29979154 0.86 ALDH1A1 (0.48) ALDH1A1MCOLN2LMNAMEN1KMT2A
SCHEMBL23057150 0.86 ALDH1A1 (0.48) ALDH1A1MCOLN2LMNAMEN1KMT2A
SCHEMBL23057145 0.85 L3MBTL1 (0.53) ALDH1A1MCOLN2LMNAPOLBGAA
SCHEMBL23057173 0.82 MCOLN2 (0.44) ALDH1A1MCOLN2LMNAGAAMEN1
SCHEMBL29978499 0.82 MCOLN2 (0.44) ALDH1A1MCOLN2LMNAGAAMEN1
SCHEMBL29979661 0.81 GAA (0.51) ALDH1A1MCOLN2LMNAPOLBGAA
SCHEMBL23057226 0.81 ALDH1A1 (0.55) ALDH1A1MCOLN2LMNAPOLBGAA
SCHEMBL24871275 0.81 L3MBTL1 (0.55) ALDH1A1MCOLN2LMNAPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 ALDH1A1 1368/4885MCOLN2 2/4885LMNA 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.